+499.5%
MRNA vs INFY
-26.8%
+526.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INFY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.2% | +1.0% | -0.8% |
| 7D | +5.5% | -2.9% | +8.4% | +6.8% |
| 30D | +158.7% | -6.2% | +165.0% | +164.6% |
| 3M | +182.1% | -4.9% | +187.0% | +186.7% |
| 6M | +151.8% | -16.6% | +168.4% | +165.8% |
| YTD | +393.6% | -32.9% | +426.5% | +455.7% |
| 1Y | +499.5% | -26.9% | +526.3% | +553.3% |
| All | +499.5% | -26.8% | +526.2% | +553.3% |
Cumulative growth
Daily Returns
Daily percentage return beside INFY.
Daily Out/Under-Performance
Portfolio return minus INFY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INFY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INFY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling